BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9219391)

  • 1. Measurement properties of quantitative urine benzoylecgonine in clinical trials research.
    Delucchi KL; Jones RT; Batki SL
    Addiction; 1997 Mar; 92(3):297-302. PubMed ID: 9219391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative urine levels of cocaine and other substances of abuse.
    Wilkins JN
    NIDA Res Monogr; 1997; 175():235-52. PubMed ID: 9467802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine toxicology samples in cocaine treatment trials: how many need to be tested?
    Delucchi KL; Batki SL; Moon J; Jacob P; Jones RT
    J Addict Dis; 2002; 21(2):17-26. PubMed ID: 11916369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplified quantitation of urinary benzoylecgonine in cocaine addiction research and for related pharmacotherapeutic trials.
    Peters JE; Chou JZ; Ho A; Reid K; Borg L; Kreek MJ
    Addiction; 1996 Nov; 91(11):1687-97. PubMed ID: 8972926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative versus qualitative urinalysis for benzoylecgonine in clinical trials for the assessment of cocaine use.
    Li SH; Chiang CN; Tai BC; Marschke CK; Hawks RL
    Psychopharmacol Bull; 1995; 31(4):671-9. PubMed ID: 8851639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of cocaine use with quantitative urinalysis and estimation of new uses.
    Preston KL; Silverman K; Schuster CR; Cone EJ
    Addiction; 1997 Jun; 92(6):717-27. PubMed ID: 9246799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SRPHK1 outcome measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study day.
    Somoza E; Somoza P; Lewis D; Li SH; Winhusen T; Chiang N; Vocci F; Horn P; Elkashef A
    Drug Alcohol Depend; 2008 Jan; 93(1-2):132-40. PubMed ID: 18029115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of quantitative urinalysis in monitoring cocaine use.
    Preston KL; Silverman K; Schuster CR; Cone EJ
    NIDA Res Monogr; 1997; 175():253-64. PubMed ID: 9467803
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations.
    Batki SL; Manfredi LB; Jacob P; Jones RT
    J Clin Psychopharmacol; 1993 Aug; 13(4):243-50. PubMed ID: 8376611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged presence of metabolite in urine after compulsive cocaine use.
    Burke WM; Ravi NV; Dhopesh V; Vandegrift B; Maany I
    J Clin Psychiatry; 1990 Apr; 51(4):145-8. PubMed ID: 2182612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity testing of commercial urine cocaine metabolite assays: I. Assay detection times, individual excretion patterns, and kinetics after cocaine administration to humans.
    Cone EJ; Menchen SL; Paul BD; Mell LD; Mitchell J
    J Forensic Sci; 1989 Jan; 34(1):15-31. PubMed ID: 2918277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of hair analyses for drugs of abuse and comparison with self-reports and urine tests.
    Musshoff F; Driever F; Lachenmeier K; Lachenmeier DW; Banger M; Madea B
    Forensic Sci Int; 2006 Jan; 156(2-3):118-23. PubMed ID: 16410161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures.
    Hattab EM; Goldberger BA; Johannsen LM; Kindland PW; Ticino F; Chronister CW; Bertholf RL
    Ann Clin Lab Sci; 2000 Jan; 30(1):85-91. PubMed ID: 10678589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is quantitative urinalysis more sensitive?
    Li SH; Chiang N; Tai B; Marschke CK; Hawks RL
    NIDA Res Monogr; 1997; 175():265-86. PubMed ID: 9467804
    [No Abstract]   [Full Text] [Related]  

  • 15. Urine testing for drug use among male arrestees--United States, 1989.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1989 Nov; 38(45):780-3. PubMed ID: 2509890
    [No Abstract]   [Full Text] [Related]  

  • 16. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
    Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD
    Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of unique cocaine metabolites and smoking by-products in postmortem blood and urine specimens.
    Jenkins AJ; Goldberger BA
    J Forensic Sci; 1997 Sep; 42(5):824-7. PubMed ID: 9304829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cocaine: considerations when assessing cocaine use by urinalysis.
    Jones RT
    NIDA Res Monogr; 1997; 175():221-34. PubMed ID: 9467801
    [No Abstract]   [Full Text] [Related]  

  • 19. Levels of cocaine and its metabolites in washed hair of demonstrated cocaine users and workplace subjects.
    Cairns T; Hill V; Schaffer M; Thistle W
    Forensic Sci Int; 2004 Oct; 145(2-3):175-81. PubMed ID: 15451090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence.
    Elkashef A; Holmes TH; Bloch DA; Shoptaw S; Kampman K; Reid MS; Somoza E; Ciraulo D; Rotrosen J; Leiderman D; Montgomery A; Vocci F
    Addiction; 2005 Mar; 100 Suppl 1():91-101. PubMed ID: 15730353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.